AU vs CC
AngloGold Ashanti plc vs The Chemours Company — AI-powered side-by-side comparison
AU
AngloGold Ashanti plc
67
Buy
VS
CC
The Chemours Company
44
Reduce
| Metric | AU | CC |
|---|
| AI Score |
67
|
44
|
| Price |
$97.51
|
$14.81
|
| P/E Ratio |
12.97×
|
-7.40×
|
| ROE |
32.6%
|
-154.4%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
53.5%
|
15.3%
|
| Debt / Equity |
0.20×
|
-82.92×
|
| Dividend Yield |
4.7%
|
2.4%
|
| RSI (14) |
80.5
|
36.7
|
| Beta |
0.702
|
1.428
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for AU versus CC.
AU leads by 23 points.
AU scores 67/100 (Buy) versus CC at 44/100 (Reduce).
AU Committee View
67% agreement
6 analysts
The primary driver is revenue growing 29.4% yoy -- genuine top-line momentum. The main limiting factor is rsi at 80 is in overbought territory. The committee is constructive but not yet at full conviction.
Bull Case
- P/E of 12.9 is inexpensive for the broad market — Value
- ROE of 45.8% shows genuine earnings power backing the valuation — Value
- Dividend yield of 3.7% pays you to wait — Value
Bear Case
- Price-to-book of 5.4x prices in significant intangible value — Value
- RSI at 80 is in overbought territory — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical
CC Committee View
50% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -1.4% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
- Beta of 1.37 means this name should amplify a favorable market regime — Macro
Bear Case
- Price-to-book of 7.1x prices in significant intangible value — Value
- ROE of only -164.4% -- cheap may mean cheap for a reason — Value
- Debt-to-equity of 16.56 adds balance-sheet risk to the value case — Value